Emerging therapies for lowering Lp(a): ‘Peering into the future’
BOSTON — There are a number of emerging therapies in development for lowering lipoprotein(a), and later-stage trials are underway.Interest continues to grow in lipoprotein(a), commonly known as Lp(a), both as a risk factor for CVD, as well as therapies to lower levels of Lp(a).